Dieter Gericke

Dieter Gericke represents public and private companies and investors of all industries in international takeovers, mergers, acquisitions, divestitures, carve-outs, joint ventures, private equity and capital market transactions. Dieter has also extensive experience in shareholder activism, takeover defense and contested acquisitions, and is a go-to lawyer for IPOs.

Head of Corporate / M&A team 2014 - 2024, Co-Head of Healthcare/Life Sciences, Head of China Group since 2010, Partner since 2004, joined Homburger in 2000. Foreign associate Wilmer Hale, Boston, 1999. Associate at Zurich law firm 1996-1998. Legal assistant University of Zurich 1994-1995. Law clerk Court of Meilen 1991-1993.

Zurich Bar Association, IBA (Corporate / M&A Law Committee, Securities Law Committee).

Various publications and speaking assignments in M&A, equity capital markets, private equity and corporate law.

Harvard (LL.M., 1999); University of Zurich (Dr. iur., summa cum laude, 1996; lic. iur., summa cum laude, 1991); Université de Paris II (Assas).

Recent assignments include advising SoftwareOne in the unsolicited approach by Bain Capital, Tencent on its investments in Global Blue, Bobst Group in the take private by JBF Finance, CSL in the public takeover of Vifor Pharma, ChemChina in the public takeover of Syngenta, EF in the sale of its China kids business, Therachon in the sale to Pfizer, Meyer Burger in a proxy fight and capital increase, KKR in the acquisition of Biosynth, Bühler in the acquisition of Haas Group, Givaudan in the acquisition of Induchem, Infront Sports & Media in the sale to Dalian Wanda or Nestlé in the sale of Alcon to Novartis.